Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Versatile Cutter Solution for Multiple Materials

June 21, 2010 7:19 am | Applimotion, Inc. | Product Releases | Comments

Eraser’s Model MMC71 Multi-Material Cutter is an all-electric, fully programmable, bench-top cutter capable of processing a wide variety of material types and compositions...

Direct Drive Frameless Motors Kits up to One Meter Diameter

June 21, 2010 7:11 am | Applimotion, Inc. | Product Releases | Comments

Applimotion’s LARC Series are available up to one meter in diameter. Driven by customer demand and new applications in large size with large scale through hole, Applimotion has expanded its offering to cover the need.

Encouraging results from the largest clinical study ever conducted on treating depression with Omega-3

June 21, 2010 6:38 am | by EurekAlert | News | Comments

(Centre hospitalier de l'Université de Montréal) The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Francois Lesperance of the Centre de recherche du Centre hospitalier at the...

TOPICS:
Advertisement

FDA to expedite ev3's Pipeline

June 21, 2010 6:37 am | by Mass Device | News | Comments

The Food & Drug Administration grants ev3 Inc. an expedited review of the pre-market approval application the company filed in May for its Pipeline cerebral aneurysm treatment. One of Covidien plc's (NYSE:COV) pending acquisitions won some good news from the Food & Drug...

TOPICS:

Covidien registers for debt sale to cover $2.3 billion ev3 buyout

June 21, 2010 6:36 am | by Mass Device | News | Comments

Covidien plc registers for an offering of an undisclosed amount of debt, aimed at raising cash to help pay for its $2.3 billion buyout of ev3 Inc. Covidien plc (NYSE:COV) registered for a debt offering with the Securities & Exchange Commission, aiming to drum up some cash...

TOPICS:

Sinapis Pharma Commences Phase I Trial

June 21, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

JACKSONVILLE, Fla. , June 21 /- Sinapis Pharma, Inc. announces that its first patients were dosed in a Phase I clinical trial study on June 14, 2010 . This study, in human volunteers, is designed to evaluate the safety, pharmacokinetics, and absolute bioavailability of an intravenous...

TOPICS:

Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems

June 21, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

DOHA, Qatar , June 21 /- One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital in Doha, Qatar , has treated nine brain...

TOPICS:

U.S. FDA Approves Improved Performance of Riverain Medical's OnGuard Chest X-ray Computer-Aided Detection Technology

June 21, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

DAYTON, Ohio , June 21 /- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard™ Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may...

TOPICS:
Advertisement

New possibility to determine the severity of appendicitis

June 21, 2010 6:34 am | by EurekAlert | News | Comments

(University of Gothenburg) The symptoms of appendicitis are often diffuse and it can be difficult to obtain an accurate diagnosis early in the course of the disease. It may be possible to predict the severity from a blood sample, and in this way determine the treatment on an...

TOPICS:

BD and PEPFAR Collaboration Initiates Program to Improve Blood-Drawing Practices in Clinics and Hospitals in Sub-Saharan Africa

June 21, 2010 6:34 am | by Becton, Dickinson and Company | News | Comments

(June 21, 2010) -- BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control an

TOPICS:

ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services

June 21, 2010 6:34 am | by RealWire | News | Comments

PHILADELPHIA, 21 June 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing...

TOPICS:

CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer

June 21, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario , June 21 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Careâ„¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for...

TOPICS:

Magic Power Coffee: Undeclared Drug Ingredient

June 21, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.

TOPICS:

Cardiovascular Devices Market Outlook June Update by ReportsandReports

June 21, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

DALLAS , June 21, 2010 /- ReportsandReports announces it Will Carry Cardiovascular Devices Market Outlook 2016 June reports in its store. Netherlands Cardiovascular Devices Market Outlook to 2016 ( http://www.reportsandreports.com/market-reports/netherlands-cardiovascular-de...

TOPICS:

California Cryobank Welcomes New Director of Quality/Regulatory Affairs

June 21, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , June 21 /- California Cryobank (CCB), a worldwide leader in biotechnology services, is proud to announce the recent hiring of Rama Tyagi as the company's Director of Quality/Regulatory Affairs. Tyagi's hiring into the newly created position echoes CCB's ongoing commitment to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading